Vicki L. Sato
Director at Vir Biotechnology; Director at Denali Therapeutics; Director at Allogene Therapeutics. Based in San Francisco, California.
- Rank
- 7844th of 14,644
- Companies held
- 3
- Largest holding
- VIR, 82.2% of total
- Latest SEC filing
- May 1, 2026
What the $11.6M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Vir Biotechnology VIR Common Stock | Directly | 1,078,391 | $8.87 | $9.6M | 82.2% | Form 4, May 1, 2026 |
| Denali Therapeutics DNLI Common Stock | Directly | 107,976 | $18.20 | $2.0M | 16.9% | Form 4, Jan 2, 2025 |
| Allogene Therapeutics ALLO Common Stock | Directly | 162,575 | $0.67 | $108K | 0.9% | Form 4, Jun 5, 2024 |
Share counts are the amounts Vicki L. Sato reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| May 1, 2026 | Sold | VIR | 22,000 | $10.05 | $221K | View |
| Apr 1, 2026 | Sold | VIR | 22,000 | $9.07 | $200K | View |
| Mar 2, 2026 | Sold | VIR | 200 | $9.98 | $2K | View |
| Mar 2, 2026 | Sold | VIR | 21,800 | $9.50 | $207K | View |
| Feb 24, 2026 | Sold | VIR | 42,177 | $9.75 | $411K | View |
| Feb 24, 2026 | Sold | VIR | 200 | $10.26 | $2K | View |
| Feb 2, 2026 | Sold | VIR | 22,000 | $7.71 | $170K | View |
| Jan 2, 2026 | Sold | VIR | 22,000 | $5.93 | $130K | View |
| Dec 1, 2025 | Sold | VIR | 22,000 | $6.00 | $132K | View |
| Nov 3, 2025 | Sold | VIR | 22,000 | $5.64 | $124K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 7841 | Thomas A. Murray EVP, CMO U.S., Somnigroup International. Lexington, KY | $11.6M |
| 7842 | Debra L. Reed Director, Caterpillar. Irving, TX | $11.6M |
| 7843 | Gerald F. Smith Jr. Director, First National. Strasburg, VA | $11.6M |
| 7844 | Vicki L. Sato Director, Vir Biotechnology. San Francisco, CA | $11.6M |
| 7845 | Jack Davison Chief Commercial Officer, Genius Sports | $11.6M |
| 7846 | Kevin E. Comolli Director, Varonis Systems. Miami, FL | $11.6M |
| 7847 | T. Paul Davis Senior Vice President, PBF Energy. Parsippany, NJ | $11.6M |
Other Vir Biotechnology insiders
All VIR insiders- George A. Scangos$23.6MDirector. #3688 overall
- Backer Marianne De$9.4MPresident and CEO. #8334 overall
- Robert Nelsen$5.5MDirector. #13438 overall
- Robert J. More$5.0MDirector. #14497 overall
- Phillip A. Sharp$1.5MDirector. #2945 overall
- Ramy Farid$284KDirector. #8183 overall
Questions
How much stock does Vicki L. Sato own?
Vicki L. Sato holds $11,638,913 in listed stock based on SEC filings and current prices, mostly Vir Biotechnology (VIR). That ranks 7844th on the Stock Rich List.
Is this Vicki L. Sato's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Vicki L. Sato last buy or sell stock?
The most recent open-market trade on file is a sale of 22,000 VIR shares on May 1, 2026 at $10.05.